相关实验视频

Updated: Jun 5, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

发现了一种用于EGFR降解的分子合剂

Hairui Wang^1,2, Hui Wang³, Rui Wang⁴

¹Department of Breast Cancer, Third Affiliated Hospital, Kunming Medical University, Kunming, Yunnan, China.

|December 3, 2024

概括

一种新型的分子,CDDO-Me,针对表皮生长因子受体 (EGFR) 在三阴性乳腺癌 (TNBC) 中降解. 这种方法显示了通过降低EGFR水平来治疗TNBC的潜力.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药物发现药物发现药物发现

背景情况:

异常的表皮生长因子受体 (EGFR) 表达驱动瘤发病.
在三阴性乳腺癌 (TNBC) 中向EGFR提出了重大的药理挑战.
分子 (MG) 降解剂为有针对性的蛋白质去除提供了一种新的策略.

研究的目的:

确定和描述一种能够降解EGFR的新分子.
研究分子剂诱导EGFR降解的机制.
在TNBC的临床前模型中评估分子的治疗潜力.

主要方法:

一种新型分子的鉴定,CDDO-Me.
研究CDDO-Me,EGFR和KEAP1 (E3-ubiquitin结合酶适配器) 之间的相互作用.
评估EGFR无化和降解途径 (自取决于 lysosomal 途径).
在细胞衍生的异种移植和患者衍生的有机体模型中评估CDDO-Me的疗效.

主要成果:

CDDO-Me诱导了EGFR和KEAP1之间的结合,导致EGFR无化和降解.
降解通过一种自依赖的溶酶体路径发生,涉及与EGFR的氨酸激酶域的直接相互作用.
KEAP1 knockdown 减少了EGFR的降解,证实了它在这个过程中的作用.
在临床前模型中,CDDO-Me通过加速EGFR降解来减轻TNBC的进展.

结论:

CDDO-Me是一种针对EGFR的新型分子降解剂.
该机制涉及KEAP1介导的泛化和EGFR的自依赖的溶酶体降解.
CDDO-Me显示出对三阴性乳腺癌的显著治疗潜力.

更多相关视频

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy

Published on: September 11, 2015

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...